Multimodal AI distinguishes ten dementia etiologies across nine clinical datasets
A multimodal AI model analyzed demographics, personal and family history, medications, cognitive and functional testing, and neuroimaging across nine datasets totaling 51,269 participants. It assigned probabilities to ten primary or contributing dementia etiologies and addressed mixed cases. The paper reports microaveraged AUROC 0.96 for dementia-etiology differentiation; model probabilities aligned with etiology-specific biomarkers and postmortem pathology. In a review of 100 cases, AI-augmented neurologist assessment outperformed neurologist-only ratings.
Technology: Multimodal machine-learning model combining clinical, neuropsychological, functional and neuroimaging data
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
Result, AI contribution and limits
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
- Publication status: Peer-reviewed paper
- Test type: retrospective or benchmark
- Tested: A multimodal AI model analyzed demographics, personal and family history, medications, cognitive and functional testing, and neuroimaging across nine datasets totaling 51,269 participants.
- Still unknown: The nine-dataset analysis is retrospective and includes in-house as well as external cohorts. The 100-case clinician comparison is small, and the study did not test prospective changes in care or patient outcomes. The authors call for prospective studies before claiming improved patient care. Model probabilities aligned with available biomarkers and postmortem evidence but are not histopathologic confirmation for every individual prediction.
- AI role: The model integrated routinely collected clinical variables and multimodal neuroimaging to estimate cognitive status and probabilities for ten dementia etiologies, including mixed etiologies and cases with incomplete features. It was evaluated across independent cohorts and compared with neurologist assessments; its output is the etiology-specific classification and probability result.
Evidence sources: https://pubmed.ncbi.nlm.nih.gov/38965435/
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: linked separately.
Review scope and date are not recorded; source checked does not establish full-text review.
Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 209 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.
Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.
Follow-up and relationships
No follow-up recorded; this is not a claim that no follow-up exists.
Follow-up review scope and date are not recorded.
No source-supported relationships recorded.